ADMA Biologics, Inc.
ADMA
$16.58
$0.000.00%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 49.38M | 36.43M | 34.22M | 26.90M | 111.90M |
| Total Depreciation and Amortization | 2.05M | 2.02M | 2.06M | 1.97M | 1.94M |
| Total Amortization of Deferred Charges | 197.00K | 170.00K | 160.00K | 190.00K | 219.00K |
| Total Other Non-Cash Items | 6.54M | 11.99M | 7.71M | 8.01M | -77.57M |
| Change in Net Operating Assets | -22.52M | -37.32M | -23.00M | -56.75M | 13.72M |
| Cash from Operations | 35.64M | 13.29M | 21.14M | -19.68M | 50.22M |
| Capital Expenditure | -1.08M | -14.37M | -2.42M | -4.70M | -2.76M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 808.00K | 0.00 | -105.00K | -19.00K | 7.00K |
| Cash from Investing | -276.00K | -14.37M | -2.53M | -4.72M | -2.75M |
| Total Debt Issued | 0.00 | 75.00M | 30.00M | -- | -- |
| Total Debt Repaid | -469.00K | -75.47M | -30.00M | -- | -30.00M |
| Issuance of Common Stock | 430.00K | 389.00K | 2.06M | 101.00K | 443.00K |
| Repurchase of Common Stock | -9.07M | -24.00M | -1.19M | -7.23M | -644.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -13.00K | -3.74M | -825.00K | -- | -825.00K |
| Cash from Financing | -9.12M | -27.83M | 48.00K | -7.13M | -31.03M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 26.25M | -28.90M | 18.66M | -31.52M | 16.44M |